Geisinger Health System
With drugs on the horizon for treating and possibly preventing transthyretin amyloid cardiomyopathy, cardiologists are weighing the pros and cons of genetic screening.
Genomic Screening Uncovers Actionable Results in Thousands of Exome-Sequenced MyCode Participants
Using exome sequence profiles for some 175,000 individuals, researchers returned genetic risk data to 5,052 Geisinger MyCode Community Health Initiative participants.
Geisinger Expands Preventive Genomic Screening Capabilities With Platform Supported by AWS Grant
Premium
The new platform is expected to advance the MyCode population genomics program by being more user-friendly and automated.
Exome Sequencing for Cerebral Palsy Has Sufficient Diagnostic Yield for First-Tier Test
A meta-analysis of prior studies found that the diagnostic yield of exome sequencing for cerebral palsy exceeded 31 percent, similar to other neurodevelopmental disorders.
Survey Suggests Polygenic Embryo Screening Has Higher Public Acceptance Than Anticipated
A national survey of more than 6,800 US participants asked about attitudes towards polygenic embryo screening, germline genome editing, and SAT prep courses.